SCHEMBL6710109

SCHEMBL6710109

CSCCOc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3nnn[nH]3)n(C)c12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.35
HIF1A Q16665 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
LMNA P02545 2/20 0.34
MAPT P10636 1/20 0.34
GPR35 Q9HC97 6/20 0.33
GRK6 P43250 1/20 0.31
BACE1 P56817 1/20 0.31
TP53 P04637 2/20 0.31
GRM5 P41594 1/20 0.31
CYP1A2 P05177 2/20 0.30
CYP3A4 P08684 2/20 0.30
CYP2C9 P11712 2/20 0.30
CYP2C19 P33261 2/20 0.30
CYP2D6 P10635 1/20 0.30
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30
USP2 O75604 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712280 0.91 NPSR1 (0.36) NPSR1HIF1ARXFP1LMNAMAPT
SCHEMBL6710193 0.91 PPARG (0.36) RXFP1LMNAMAPTTP53GRM5
SCHEMBL6710598 0.90 MAPT (0.36) NPSR1HIF1ARXFP1LMNAMAPT
SCHEMBL6707789 0.89 LMNA (0.33) RXFP1LMNAMAPTHSD17B10
SCHEMBL6708785 0.89 HIF1A (0.38) NPSR1HIF1ARXFP1LMNAMAPT
SCHEMBL6710246 0.87 GPR35 (0.34) NPSR1HIF1ARXFP1LMNAMAPT
SCHEMBL6711695 0.87 HIF1A (0.39) NPSR1HIF1ARXFP1LMNAMAPT
SCHEMBL6708000 0.86 KDM1A (0.37) NPSR1HIF1ARXFP1LMNAMAPT
SCHEMBL6710199 0.85 HIF1A (0.35) NPSR1HIF1ARXFP1LMNAMAPT
SCHEMBL6710196 0.85 HIF1A (0.35) NPSR1HIF1ARXFP1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 NPSR1 2999/4885HIF1A 296/4885RXFP1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.